By Victoria Masterson A SPIN-OUT from the University of Edinburgh has raised £1 million to develop a new device that could “revolutionise” the early diagnosis and monitoring of difficult to detect cancers, such as kidney, thyroid and brain cancer. BioCaptiva raised the seed investment from business angel syndicate, Archangels, and economic development agency Scottish Enterprise for its ‘BioCollector’ device. The company says this overcomes “significant limitations” of current liquid biopsy testing – where blood is analysed for cells from cancerous tumours. “We are confident that this platform technology can make a significant impact in this important area and, ultimately, enable cancers to be detected more quickly and accurately, enabling patients to receive precision cancer treatment as early as possible,” said BioCaptiva chief executive Jeremy Wheeler.
NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Endo International Plc is trying to get more breathing room on its debt as it contests with ongoing opioid and patent litigation and an expected drop in earnings.The drug company said it will issue new debt to refinance its $3.3 billion loan coming due in 2024, leaving the same guarantees and collateral in place while pushing out the due date, according to a statement Thursday. The financing, if completed, is not expected to increase Endo’s total debt load.The company is in talks for a $2.295 billion first-lien term loan managed by JPMorgan Chase & Co., for which commitments are due March 11, according to people familiar with the matter. Endo is also planning to borrow $1 billion in other senior secured first-lien debt, said the people, who asked not to be identified as the details are private.Endo is one of several pharmaceutical companies accused of downplaying opioids’ risks and over-selling their benefits, and finds itself tangled in expensive, ongo
Operator
Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions]
I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead.
Laure Park
Senior Vice President, Investor Relations and Corporate Affairs
Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining me on today s call are Blaise Coleman, President and CEO of Endo; Mark Bradley, Executive Vice President and CFO; and Patrick Barry, Executive Vice President and President, Global Commercial Operations.
Forsyth resident awarded YMCA Volunteer of the Year forsythnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forsythnews.com Daily Mail and Mail on Sunday newspapers.